An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study
Clinical trial NCT05271370 · TERMINATED
Trial details
- NCT number
- NCT05271370
- Sponsor
- CytoDyn, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-29
- Primary completion
- 2022-06-20
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.